Výsledky vyhledávání - "bone metastasis prostate cancer"

Akademický článek

Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer

Autor: Lu Y, Jiang W, Wu X, Huang S, Huang Z, Shi Y, Dai Q, Chen J, Ren F, Gao S

Publikováno v: International Journal of Nanomedicine, Vol Volume 13, Pp 6913-6927 (2018)

Yue Lu,1 Wenjun Jiang,1 Xin Wu,2 Saixu Huang,1 Zhiyong Huang,1 Yamin Shi,3 Qi Dai,1 Jianming Chen,2 Fuzheng Ren,1 Shen Gao4 1Shanghai Key Lab New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, People’s R

Externí odkaz: https://doaj.org/article/467fffbaf1d84378bccfee5554f22d1d

Zobrazit plný text záznamu

Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer

Autor: Chen Jianming, Wenjun Jiang, Zhiyong Huang, Qi Dai, Lu Yue, Xin Wu, Shen Gao, Yamin Shi, Saixu Huang, Fuzheng Ren

Publikováno v: International Journal of Nanomedicine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad5b4ebf5fb750aa15bc2ae937cb3191
https://pubmed.ncbi.nlm.nih.gov/30464450

Zobrazit plný text záznamu

The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience

Autor: Renato Costa, Alessandra Murabito, Vincenzo Tripoli, Rossella De Luca, Giuseppe Cicero

Publikováno v: Oncology. 94(3)

Background/Aim: Prostate cancer frequently causes bone metastases and skeletal events that impair quality of life (QoL) and survival. The alpha emitter radium-223 is a new drug that improves treatment in men with castration-resistant prostate cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46c8659ecb4165787821761769efc55
https://pubmed.ncbi.nlm.nih.gov/29241166

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer

Autor: Adrian C. Herington, Rachael Collard, Loan Bui, Judith A. Clements, Jin Gao, David Nicol

Publikováno v: Prostate

BACKGROUND: Prostate cancer (PCa) and bone cell interactions are critical in the metastatic phase. Kallikrein 4 (KLK4/hK4) is expressed in both PCa and mineralized tissues. We determined if KLK4/hK4 expression was associated with, and influenced by,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f47a955db37c000f095a4ec6aa12620d
https://doi.org/10.1002/pros.20465

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání